title: Stroke prevention: the emerging strategies.
abstract: Warfarin prophylaxis in patients with nonvalvular atrial fibrillation may be one of the most valuable public-health interventions. Barriers to its optimal utilization include wariness about bleeding complications and concern about age-related sensitivity to the drug. The risks, however, may be minimized by creation of anticoagulation clinics to ensure optimal dosing and follow-up.
authors.affiliation: Duke University, USA.
authors.forename: D C
authors.initials: DC
authors.lastname: McCrory
authors.forename: D B
authors.initials: DB
authors.lastname: Matchar
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control*; D003663:Decision Trees; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications*; D011634:Public Health; D012307:Risk Factors; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin